Hero Orthopedics, LLC appears in FDA 510(k) records as the applicant behind the HERO Sternal Closure System, cleared under K262939 with a substantially equivalent decision dated November 2, 2026. The submission was received August 21, 2026, reviewed under the orthopedic advisory committee, and assigned product code HRS. Independent regulatory trackers that index openFDA data list the same single clearance for the firm, and the company's own site describes collaboration with orthopedic surgeons without naming additional products. [1][2][5]
The documented clearance and its review path
K262939 was filed as a Traditional 510(k) with a Summary statement, no third-party review, and no expedited review flag. FDA recorded the applicant at 700 Park Ave., Suite F, Winona Lake, IN 46590, and the decision description reads Substantially Equivalent. The device sits in the orthopedic review panel under regulation 21 CFR 888.3030. [1][3]
FDAcleared.org, an independent tracker of openFDA clearances, reports a 73-day review interval for this submission and characterizes the firm's clearances as entirely orthopedic. That interval is the tracker's own calculation from the filing dates, not an FDA-published performance figure. [6]
Product code context
Product code HRS covers metallic bone fixation plates and accessories intended for implantation, classified as Class 2 under 21 CFR 888.3030. Innolitics, which publishes FDA device hierarchies, lists the code as an implant category within Subpart D, Prosthetic Devices, and counts 31 clearances across all holders of the code. Hero Orthopedics' K262939 is one of those clearances. [8][3]
The HERO Sternal Closure System is the only product name tied to this applicant in the indexed records. No other device names, components or indications appear in the linked filings, so the system's specific configuration is not documented in these sources. [1][7]
Portfolio counts as recorded
The linked collection contains one 510(k) record, and the decision count for that collection is one Substantially Equivalent decision. The smaller record sample likewise holds a single entry, K262939, so the sample and the full collection coincide here. These are counts of indexed filings as of the retrieval date, not measures of company output, sales or safety history. [1][5]
DeviceClearance and Arca, both independent aggregators of openFDA data, independently report one 510(k) clearance for the firm, cleared in 2026, with HRS as the only product code. FDAcleared.org reports zero PMA approvals and zero recall actions in its index; that absence reflects indexed records only. [7][5][6]
Applicant identity and published company material
The company's own website states that it works with orthopedic surgeons and describes advancing orthopedic care through surgeon-led innovation and anatomical integrity. The site lists the same Winona Lake, Indiana address used in the FDA filing and provides a general contact email. No parent company, brand family or ownership structure is verified in these sources. [2]
The FDA record names Russell Parrott as the filing contact. That role is a regulatory correspondence detail and does not establish an executive title or organizational chart. [1]
